EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSAMXG00000010402
Gene Symbol: RPS9
1 Cross references
237 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSAMXG00000033451
Gene Symbol: RPSA
4 Cross references
518 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSAMXG00000029436
Gene Symbol: RPLP1
3 Cross references
386 Possible Orthologues:

Selectin P

Ensembl ID : ENSAMXG00000043683
Gene Symbol: SELP
1 Cross references
172 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSAMXG00000036419
Gene Symbol: LOC103031835
3 Cross references
250 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3-Like

Ensembl ID : ENSAMXG00000001028
Gene Symbol: LOC103024220
3 Cross references
178 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSAMXG00000018053
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Si:dkey-211g8.7

Ensembl ID : ENSAMXG00000042863
Gene Symbol: SI:DKEY-211G8.7
1 Cross references
273 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSAMXG00000009814
Gene Symbol: SIGMAR1
3 Cross references
206 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSAMXG00000029788
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha-Like

Ensembl ID : ENSAMXG00000012098
Gene Symbol: LOC103035061
3 Cross references
245 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha-Like

Ensembl ID : ENSAMXG00000021379
Gene Symbol: LOC103037861
3 Cross references
263 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).